GlaxoSmithKline acquires remaining 30% of its Indonesian Consumer Healthcare business
The transaction, which is with three connected entities, also includes GSK divesting a non-core brand and a manufacturing facility in the country. GSK has also divested its Insto
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.